Announce Date | 04/22/2025 |
EPS Normalized Actual | $4.06 (Beat by $0.42) |
EPS GAAP Actual | $4.06 (Beat by $0.42) |
Revenue Actual | $13.405B |
Revenue Surprise | Beat by $13405M |
Announce Date | 12/31/1969 (Pre-Market) |
EPS Normalized Estimate | $ |
EPS GAAP Estimate | $ |
Revenue Estimate | $0B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2028 | 20.68 | 10.57 | 19.86647 | 21.14254 | 1 |
Dec 2027 | 20.50333 | 10.67 | 19.69675 | 20.96192 | 1 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ1 2025 (Mar 2025) | 3.46 | 3.46 | 13.405B | 2.34% | 13405M |
FQ4 2024 (Dec 2024) | 2.67 | 2.67 | 10.19B | -28.87% | 10190M |
FQ3 2024 (Sep 2024) | 4.42 | 4.42 | 13.798B | 32.12% | 13798M |
FQ2 2024 (Jun 2024) | 1.53 | 1.53 | 13.24B | 31.93% | 13240M |
FQ1 2024 (Mar 2024) | 3.29 | 3.29 | 13.091B | 31.99% | 13091M |
FQ4 2023 (Dec 2023) | 1.67 | 1.67 | 13.132B | 31.16% | 13132M |
FQ3 2023 (Sep 2023) | 4.46 | 4.46 | 9.366B | 5.99% | 9366M |
FQ2 2023 (Jun 2023) | 3.53 | 3.53 | 9.012B | 8.66% | 9012M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ3 2028 (Sep 2028) | 6.51 | -- | 5.99199 | 9.48747 | 6 |
FQ2 2028 (Jun 2028) | 6.5 | -- | 5.98278 | 9.47289 | 4 |
FQ1 2028 (Mar 2028) | 6.29 | -- | 5.78949 | 9.16685 | 4 |
FQ4 2027 (Oct 2027) | 5.537 | -- | 5.37212 | 5.65216 | 6 |
FQ3 2027 (Jul 2027) | 5.2542 | -- | 5.09774 | 5.36348 | 6 |
FQ2 2027 (Jun 2027) | 5.1884 | -- | 5.03011 | 5.32252 | 7 |
FQ1 2027 (Mar 2027) | 4.0793 | -- | 3.95485 | 4.18475 | 9 |
FQ4 2026 (Oct 2026) | 4.5035 | -- | 4.3694 | 4.59717 | 9 |
FQ3 2026 (Jul 2026) | 3.996 | -- | 3.87701 | 4.07911 | 9 |
FQ2 2026 (Jun 2026) | 3.4475 | -- | 3.34233 | 3.53662 | 7 |
FQ1 2026 (Mar 2026) | 2.9123 | -18.81 | 2.82345 | 2.98758 | 9 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ3 2028 (Sep 2028) | 13.71B | -- | 12.87B | 18.54B | 3 |
FQ2 2028 (Jun 2028) | 13.44B | -- | 12.62B | 18.17B | 5 |
FQ1 2028 (Mar 2028) | 13.18B | -- | 12.37B | 17.82B | 3 |
FQ4 2027 (Oct 2027) | 21.92B | -- | 21.42B | 22.27B | 6 |
FQ3 2027 (Jul 2027) | 21.13B | -- | 20.64B | 21.47B | 6 |
FQ2 2027 (Jun 2027) | 59.09B | -- | 57.71B | 60.27B | 7 |
FQ1 2027 (Mar 2027) | 55.81B | -- | 54.5B | 56.92B | 7 |
FQ4 2026 (Oct 2026) | 11.59B | -- | 11.33B | 11.78B | 6 |
FQ3 2026 (Jul 2026) | 11.21B | -- | 10.95B | 11.39B | 6 |
FQ2 2026 (Jun 2026) | 11.21B | -- | 10.94B | 11.43B | 10 |
FQ1 2026 (Mar 2026) | 11.09B | -20.92 | 10.83B | 11.31B | 10 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
8
EPS # of Misses
0
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | 3.46 | 3.46 | 100% | |
FQ4 2024 (Dec 2024) | 2.67 | 2.67 | 100% | |
FQ3 2024 (Sep 2024) | 4.42 | 4.42 | 100% | |
FQ2 2024 (Jun 2024) | 1.53 | 1.53 | 100% | |
FQ1 2024 (Mar 2024) | 3.29 | 3.29 | 100% | |
FQ4 2023 (Dec 2023) | 1.67 | 1.67 | 100% | |
FQ3 2023 (Sep 2023) | 4.46 | 4.46 | 100% | |
FQ2 2023 (Jun 2023) | 3.53 | 3.53 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | $0B | $13.41B | $13405M | 100% |
FQ4 2024 (Dec 2024) | $0B | $10.19B | $10190M | 100% |
FQ3 2024 (Sep 2024) | $0B | $13.8B | $13798M | 100% |
FQ2 2024 (Jun 2024) | $0B | $13.24B | $13240M | 100% |
FQ1 2024 (Mar 2024) | $0B | $13.09B | $13091M | 100% |
FQ4 2023 (Dec 2023) | $0B | $13.13B | $13132M | 100% |
FQ3 2023 (Sep 2023) | $0B | $9.37B | $9366M | 100% |
FQ2 2023 (Jun 2023) | $0B | $9.01B | $9012M | 100% |